- The Pfizer–BioNTech COVID-19 vaccine, sold
under the
brand name
Comirnaty, is an mRNA-based COVID-19
vaccine developed by the
German biotechnology company...
- name
Comirnaty, is an mRNA
vaccine produced by the
German company BioNTech and the
American company Pfizer. In Hong Kong, Macau, and Taiwan,
Comirnaty is...
- Pfizer–BioNTech COVID-19
vaccine codenamed BNT162b2 (later
branded as
Comirnaty). This
approval enabled the
start of the UK's COVID-19
vaccination programme...
- Kingdom, 138,000
people had
received the Pfizer-BioNTech COVID‑19
vaccine Comirnaty by 16 December,
during the
first w**** of the UK
vaccination programme...
- is the
first RNAi drug to
receive regulatory approval. The
second is
Comirnaty, the COVID-19 mRNA
vaccine developed by Pfizer/BioNTech that has received...
- vaccines, of
which the
first authorized were COVID-19
vaccines (such as
Comirnaty and Spikevax). mRNA is
produced by
synthesising a
ribonucleic acid (RNA)...
-
cooperation with the
American company Pfizer sold
under the
brand name
Comirnaty. On 24
August 2020 WHO
stated that
COVAX had nine CEPI-supported vaccine...
-
Erstens stimmt es nicht, d**** die
Zusatzstoffe unerlaubt sind. Denn
Comirnaty ist zugel****en und
damit sind auch alle
darin enthaltenen Hilfsstoffe...
- do not
jeopardize the
quality and
integrity of the data from the main
Comirnaty trial and have no
impact on the benefit-risk ****essment or on the conclusions...
- $2
billion NxStage acquisition".
Modern Healthcare. "Package
Insert -
Comirnaty". U.S. Food and Drug Administration.
December 2021.
Retrieved 2022-05-24...
